Invitation to participate in a survey about packaging and flavor profile preferences of oral liquid/suspension medicine.
On behalf of our pharmaceutical partners, the Myotonic Dystrophy Foundation (MDF) invites you to take the following survey on your medicine packaging and flavor preferences. These Myotonic Dystrophy (DM) Drug Developers hope to evaluate the feasibility of an oral liquid/suspension treatment option for the management of symptoms related to myotonic dystrophy. Oral liquid/suspension medicines can be supplied in different packaging configurations and are available in many different flavor profiles and our partners would like to ensure they consider options that are preferred by people living with DM.
The survey should take approximately 1 minute to complete.
Participation in this survey is voluntary and you will not be asked to share any personal information to ensure participants remain anonymous. Aggregated results may be used by our DM Drug Development partners to inform internal decisions related to the preferred packaging and flavor profiles of people living with DM. The results of this survey may be shared with additional DM Drug Development companies by request.